NCT01922817View on ClinicalTrials.gov

DPP4inhibitors in Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Type 1 DiabetesHypoglycaemia
Interventions
DRUG

Saxagliptin

5mg saxagliptin

Trial Locations (1)

DD1 9SY

Clinical research centre, Ninewells Hospital and Medical School, Dundee

All Listed Sponsors
lead

University of Dundee

OTHER

NCT01922817 - DPP4inhibitors in Type 1 Diabetes | Biotech Hunter | Biotech Hunter